Wall Street Zen cut shares of Nutex Health (NASDAQ:NUTX – Free Report) from a strong-buy rating to a buy rating in a research note published on Monday morning.
NUTX has been the subject of a number of other reports. Weiss Ratings lowered Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, July 10th. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. Lake Street Capital assumed coverage on shares of Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target for the company. Finally, B. Riley Financial assumed coverage on shares of Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target for the company. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health currently has a consensus rating of “Moderate Buy” and an average price target of $243.33.
Check Out Our Latest Stock Analysis on NUTX
Nutex Health Price Performance
Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The business had revenue of $216.49 million for the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%. Equities analysts forecast that Nutex Health will post 22.72 EPS for the current fiscal year.
Institutional Trading of Nutex Health
A number of institutional investors have recently bought and sold shares of the company. Bank of America Corp DE grew its stake in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Nutex Health by 17.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after purchasing an additional 2,748 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Nutex Health during the 1st quarter worth about $522,000. JPMorgan Chase & Co. lifted its holdings in shares of Nutex Health by 41,430.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock valued at $1,034,000 after buying an additional 8,286 shares during the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Nutex Health during the 2nd quarter valued at about $454,000. Institutional investors and hedge funds own 5.32% of the company’s stock.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Further Reading
- Five stocks we like better than Nutex Health
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
